Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-26 @ 3:04 AM
Study NCT ID:
NCT05886920
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-15
First Post:
2023-05-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations
Sponsor:
D3 Bio (Wuxi) Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-10
Start Date Type:
ACTUAL
Primary Completion Date:
2028-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-04
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-24
First Submit QC Date:
None
Study First Post Date:
2023-06-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-09
Last Update Post Date:
2025-12-15
Last Update Post Date Type:
ESTIMATED